Your browser doesn't support javascript.
loading
Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammation.
Muto, Tomoya; Walker, Callum S; Agarwal, Puneet; Vick, Eric; Sampson, Avery; Choi, Kwangmin; Niederkorn, Madeline; Ishikawa, Chiharu; Hueneman, Kathleen; Varney, Melinda; Starczynowski, Daniel T.
Afiliación
  • Muto T; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Department of Hematology, Chiba University Hospital, Chiba. Tomoya.Muto@chiba-u.jp.
  • Walker CS; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Agarwal P; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Vick E; Division of Hematology and Oncology, University of Cincinnati, Cincinnati, OH.
  • Sampson A; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Choi K; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Niederkorn M; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Ishikawa C; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Department of Cancer Biology, University of Cincinnati, Cincinnati, OH.
  • Hueneman K; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Varney M; Department of Pharmaceutical Science and Research, Marshall University, Huntington, WV.
  • Starczynowski DT; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Department of Cancer Biology, University of Cincinnati, Cincinnati, OH; Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; UC Cancer Center, Ci
Haematologica ; 108(10): 2715-2729, 2023 10 01.
Article en En | MEDLINE | ID: mdl-37102608

Texto completo: 1 Colección: 01-internacional Asunto principal: Síndromes Mielodisplásicos / Proteína p53 Supresora de Tumor Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Síndromes Mielodisplásicos / Proteína p53 Supresora de Tumor Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article